The global molecular biology enzymes and kits & reagents market is projected to USD 29.7 billion by 2026 from USD 15.3 billion in 2021, at a CAGR of 14.2% during the forecast period. Growth in the molecular biology enzymes and kits & reagents market is driven by factors such as increased research activities and R&D investments in the life science industry, rising number of genome projects, technological advancements in the life science industry, and rising incidence of genetic disorders.
The global molecular biology enzymes and kits & reagents market is highly consolidated. Key players in the molecular biology enzymes and kits & reagents market include Thermo Fisher (US), Merck (Germany), Illumina (US), QIAGEN (Netherlands), New England Biolabs (US), Promega (US), Agilent (US), Roche (Switzerland), Takara Bio (Japan), Bio Basic (Canada), Jena Bioscience (Germany), Molecular Biology Resources (US), Bio-Rad Laboratories, Inc. (US). The key players in this market are increasingly focusing on strategic expansions, partnerships, and product approvals to expand their manufacturing capabilities and increase market presence.
Thermo Fisher Scientific offers a complete and integrated portfolio of solutions and services for laboratory research and analysis, healthcare, and clinical science. The Biosciences segment offers reagents, instruments, and consumables for molecular biology; protein biology; and cell imaging and analysis. These products are primarily used in agriculture, forensics, diagnostics product development, and toxicology research. The company operates in countries across North America, Europe, Asia, and Latin America.
To know about the assumptions considered for the study download the pdf brochure
Illumina is a molecular diagnostics company that develops, manufactures, and markets integrated systems for the analysis of genetic variations and biological functions. The company caters to a broad range of academic, government, pharmaceutical, biotechnology, and other leading genomic research centers by offering products for the research, clinical, and applied markets. As of January 16, 2020, the company had 799 US patents and 617 pending US patent applications along with 61 allowed applications not issued as a patent. Illumina has corporate offices in China, Japan, Singapore, the UK, Latin America, Australia, New Zealand, and the Netherlands.
Molecular Biology Enzymes & Kits & Reagents Market by Product (Kit, Reagent, Enzyme), Application (PCR, Sequencing, Epigenetic, Synthetic Biology), End user (Research Institutes, Pharma & Biotech Company, Hospitals) and Region - Global Forecast to 2026Rigid & Rigid), Point of Sale (Retail & Bulk) - Trends and Forecast to 2020
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE